AVCRFPharmaceutical PreparationsFiscal year ends December 31
Avricore Health Inc.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 16, 2025
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
Avricore Health statistics
Financials through Dec 31, 2024, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Avricore Health | Industry median |
|---|---|---|
| Market Cap | C$115.62K | C$123.83M |
| Enterprise Value | -C$1.02M | C$113.12M |
| PS Ratio | 0.02 | 1.24 |
| P/FCF Ratio | 0.14 | |
| P/OCF Ratio | 0.12 | 4.66 |
Enterprise value
| Measure | Avricore Health | Industry median |
|---|---|---|
| EV / Sales | -0.22 | 1.14 |
| EV / EBITDA | -7.69 | |
| EV / FCF | -1.23 |
Income (trailing twelve months)
| Measure | Avricore Health | Industry median |
|---|---|---|
| Revenue | C$4.66M | C$28.08M |
| Gross Profit | C$1.88M | C$13.09M |
| Pretax Income | C$129.00K | -C$10.05M |
| EBITDA | C$132.14K | -C$10.30M |
| EPS (Diluted) | -0.01 CAD | -0.14 CAD |
Margins
| Measure | Avricore Health | Industry median |
|---|---|---|
| Gross Margin | 40.4% | 41.6% |
| Pretax Margin | 2.77% | -15.6% |
| EBITDA Margin | 2.84% | -16.8% |
| FCF Margin | 17.7% | -28.3% |
Growth
| Measure | Avricore Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 33.7% | 4.81% |
| Revenue Growth (3Y CAGR) | 236.0% | 8.51% |
Balance sheet
| Measure | Avricore Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | C$1.13M | C$18.85M |
| Net Cash (Debt) | C$1.13M | C$16.52M |
| Net Cash Per Share | 0.01 CAD | 0.25 CAD |
Cash flow (trailing twelve months)
| Measure | Avricore Health | Industry median |
|---|---|---|
| Operating Cash Flow | C$1.00M | -C$6.28M |
| Capital Expenditures | -C$181.09K | -C$685.52K |
| Free Cash Flow | C$823.52K | -C$10.42M |
| FCF Per Share | 0.01 CAD | -0.07 CAD |
Efficiency
| Measure | Avricore Health | Industry median |
|---|---|---|
| Asset Turnover | 2.03 | 0.44 |
| Inventory Turnover | 5730.62 | 2.74 |
| Revenue Per Employee | C$4.66M | C$469.57K |
| Employee Count | 1 | 26 |
Dividends and yields
| Measure | Avricore Health | Industry median |
|---|---|---|
| FCF Yield | 712.2% | -10.0% |
Shares
| Measure | Avricore Health | Industry median |
|---|---|---|
| Shares Outstanding | 101,290,000 | 74,643,400 |
| Shares Change (YoY) | 0.76% | 17.9% |
| Float | 101,290,000 | 74,292,200 |
| Shares Held by Insiders | 0.00% | 0.00% |
Scores
| Measure | Avricore Health | Industry median |
|---|---|---|
| Altman Z-Score | -17.50 | 0.35 |
Calculated by StockData from Avricore Health's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.